Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.
about
Alterations in the transcriptome and antibiotic susceptibility of Staphylococcus aureus grown in the presence of diclofenac.Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance.The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods.The intrinsic resistome of bacterial pathogens.Natural remedies for non-steroidal anti-inflammatory drug-induced toxicity.Antimicrobial Effects of Antipyretics.Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review.Antibacterial Effect of Diclofenac Sodium on Enterococcus faecalisDetermination of diclofenac concentrations in human plasma using a sensitive gas chromatography mass spectrometry method.Treatment with some anti-inflammatory drugs reduces germ tube formation in Candida albicans strains.The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.One-step grafting of temperature-and pH-sensitive (N-vinylcaprolactam-co-4-vinylpyridine) onto silicone rubber for drug delivery.Comparison of anti-bacterial efficiency of ibuprofen, diclofenac, and calcium hydroxide against Enterococcus faecalis in an endodontic model: An in vitro study.Effect of Pharmaceuticals on the Performance of a Novel Osmotic Membrane Bioreactor (OMBR)Synthesis and synergistic antimycobacterial screening of chlorpromazine and its metabolites
P2860
Q35172015-C7F1696A-476C-462F-B46D-C030D0B62E32Q35666897-DD3FE692-2EA8-4764-921C-3104FCF44C7CQ35895154-82859741-D1BB-44D2-A45F-5BB8F784E48BQ38103861-4048D1F0-EBB1-40C4-B7D2-3145F312C722Q38960539-ABD10DEC-B9E8-4095-AABF-F8A1C25927B2Q39110210-A0F81060-6618-4662-AE09-D0103A169C65Q39437994-38740EF6-BE6F-4C79-B00D-78652DEE5008Q41126915-36345FAB-1EF1-42C3-AB81-E1089D9523F0Q41684411-6AA61B85-1A70-4FA4-9C1E-4C8C8EFF7CCFQ41784729-84155CBE-4AEF-461D-86CC-2AEC1264E5AEQ46432988-47267795-2E12-40CC-8E8F-A7632B8360F1Q54238795-33EA242C-0677-4801-B39F-23FC7886A718Q55209150-9C0AB23A-B9D0-4A42-9624-47E3C0A7A69AQ57265997-9741E9A6-AD32-4AC4-B0D3-425ADF68895DQ58866930-73A5D141-D6AA-4E44-A545-1549EEE3C443
P2860
Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Potential management of resist ...... matory drug diclofenac sodium.
@en
Potential management of resist ...... matory drug diclofenac sodium.
@nl
type
label
Potential management of resist ...... matory drug diclofenac sodium.
@en
Potential management of resist ...... matory drug diclofenac sodium.
@nl
prefLabel
Potential management of resist ...... matory drug diclofenac sodium.
@en
Potential management of resist ...... matory drug diclofenac sodium.
@nl
P2093
P50
P921
P1476
Potential management of resist ...... matory drug diclofenac sodium.
@en
P2093
Jette E Kristiansen
Joseph Molnar
Kaushiki Mazumdar
Subramanian Annadurai
Sujata G Dastidar
P304
P356
10.1016/J.IJANTIMICAG.2007.04.018
P577
2007-07-17T00:00:00Z